STAGG ROBERT (SVP, Clinical R&D) sold 3.9% of their position (1.69K shares) of ONCOMED PHARMACEUTICALS INC on the open market
Open‑market sale worth $3.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/10/2018ACC: 0001567619-18-003957
Officer· SVP, Clinical R&D
Since Oct 2018
-1.69K
Net shares
Net seller
$3.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.69K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.69K
Price / share
$2.13
Trade value
$3.59K
% of position
3.9%
10/9/2018
43.28K→41.60K
Total
Net shares
−1.69K
Net value
-$3.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/9/2018 | S · Sale | −1.69K | $2.13 | $3.59K | 3.9% | 43.28K | 41.60K |
| Total | −1.69K | -$3.59K | ||||||
Derivative Transactions0
No derivative transactions reported